FDA Clearance Tracker · P220004
PALMAZ MULLINS XD Pulmonary Stent
Last checked: Nov 19, 2026Latest source record: Jul 21, 2023 (this decision)Source: openFDAMethods & limitations
Decided
Jul 21, 2023
Approved
Time to decision
466 days
Received Apr 11, 2022. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA
Device class
Class III
The decision
- FDA number
- P220004
- Device name
- PALMAZ MULLINS XD Pulmonary Stent
- Applicant
- Cordis US Corp
- Applicant location
- Miami Lakes, FL
- Received
- Apr 11, 2022
- Decided
- Jul 21, 2023
- Decision
- Approved
- Supplements
- 2 in FDA's data for this PMA. See them on the FDA record
Device type
- Device type
- Pulmonary stent (QWC)
- Device class
- Class III
FDA's approval statement
As written in FDA's record.
Approval of the PALMAZ MULLINS XD Pulmonary Stent. The PALMAZ MULLINS XD Pulmonary Stent is indicated for the non-emergency treatment of pulmonary artery stenosis in pediatric patients who are at least 10kg in weight with two ventricle anatomy.
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- This is the earliest decision in FDA's data under product code QWC (Pulmonary stent).
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
Other decisions for Cordis US Corp
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K233637 · Decided Jun 28, 2024 · 228 days after receipt
Device type: Catheter, Percutaneous (DQY) · Cardiology
K232573 · Decided Nov 21, 2023 · 88 days after receipt
Device type: Catheter, Intravascular, Diagnostic (DQO) · Cardiology
K230704 · Decided Apr 24, 2023 · 41 days after receipt
Device type: Introducer, Catheter (DYB) · Cardiology
1 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.